Duffy Stephen W
Queen Mary University of London, Centre for Prevention, Detection and Diagnosis, London, UK.
J Breast Imaging. 2021 Nov 16;3(6):637-644. doi: 10.1093/jbi/wbab067.
Sweden has made a contribution to mammography screening research considerably disproportionate to its size. With 0.13% of the world's population, Sweden contributed almost half of the randomized trial evidence on mammography screening. In addition to the fundamental efficacy of screening in preventing deaths from breast cancer, Swedish researchers have produced a considerable volume of research evaluating mammography screening in the routine healthcare services setting and illuminating issues of breast cancer progression and natural history. The basic result that screening prevents deaths from breast cancer has informed policy and led to substantial preservation of life internationally.
瑞典在乳腺钼靶筛查研究方面所做的贡献与其国家规模极不相称。瑞典人口仅占世界人口的0.13%，却几乎贡献了乳腺钼靶筛查随机试验证据的一半。除了筛查在预防乳腺癌死亡方面的基本功效外，瑞典研究人员还开展了大量研究，评估常规医疗服务环境下的乳腺钼靶筛查，并阐明了乳腺癌进展和自然史的相关问题。筛查可预防乳腺癌死亡这一基本结果为政策提供了依据，并在国际上挽救了大量生命。
